skip to main content

Ipratropium glaucoma caution — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

HardRespiratory TherapeuticsIpratropium glaucoma cautionGPhC CRA

A patient with known narrow-angle glaucoma uses nebulised ipratropium through a poorly fitting mask and immediately develops a painful red eye, blurred vision and coloured haloes. What should the pharmacist advise?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: CStop ocular exposure and obtain immediate specialist assessment for possible acute angle-closure glaucoma

Explanation lettering: B = shown as A · C = shown as B · D = shown as C · E = shown as D · A = shown as E

A is unsafe because the symptom cluster is an ocular emergency. B treats the wrong mechanism and repeats the exposure. C delays sight-saving assessment. D is correct: prevent further mist entering the eye and seek immediate specialist advice for possible acute angle closure; future administration requires a correctly fitting mouthpiece or mask and clinical review. E preserves the antimuscarinic risk and makes an unsupervised treatment change.

Reference: Atrovent UDVs SmPC. https://www.medicines.org.uk/emc/product/8028/smpc